108 related articles for article (PubMed ID: 28881044)
1. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.
Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H; Alavian SM; Lankarani KB; Farrokh P; Randel Nyengaard J
Eur J Histochem; 2018 Jan; 62(1):2859. PubMed ID: 29569872
[TBL] [Abstract][Full Text] [Related]
3. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.
Nguyen TB; Roncalli M; Di Tommaso L; Kakar S
Mod Pathol; 2016 Mar; 29(3):283-92. PubMed ID: 26769138
[TBL] [Abstract][Full Text] [Related]
4. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology.
Bakheet AMH; Zhao C; Chen JN; Zhang JY; Huang JT; Du Y; Gong LP; Bi YH; Shao CK
Hepatol Int; 2020 Jan; 14(1):96-104. PubMed ID: 31832976
[TBL] [Abstract][Full Text] [Related]
5. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
[TBL] [Abstract][Full Text] [Related]
6. Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions.
Wasfy RE; Shams Eldeen AA
Asian Pac J Cancer Prev; 2015; 16(11):4769-75. PubMed ID: 26107238
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.
Ataide EC; Perales SR; Silva MG; Filho FC; Sparapani AC; Latuf Filho PF; Stucchi RSB; Vassallo J; Escanhoela CAF; Boin IFSF
Transplant Proc; 2017 May; 49(4):858-862. PubMed ID: 28457411
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.
Uthamalingam P; Das A; Behra A; Kalra N; Chawla Y
J Clin Exp Hepatol; 2018 Jun; 8(2):173-180. PubMed ID: 29892181
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
[TBL] [Abstract][Full Text] [Related]
10. RESULTS OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA AND NODULES WITH HIGH-GRADE DYSPLASIA IN PATIENTS WITH CIRRHOSIS.
Coral GP; Branco F; Meurer R; Marcon PDS; Fontes PRO; Mattos AA
Arq Gastroenterol; 2021; 58(1):82-86. PubMed ID: 33909802
[TBL] [Abstract][Full Text] [Related]
11. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R
Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy.
Sasaki M; Sato Y
Virchows Arch; 2021 Oct; 479(4):697-703. PubMed ID: 34115196
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.
Majeed S; Mushtaq S; Azam M; Akhtar N; Hussain M; Loya A
J Pak Med Assoc; 2018 Jul; 68(7):1029-1031. PubMed ID: 30317296
[TBL] [Abstract][Full Text] [Related]
14. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
Jeon Y; Kim H; Jang ES; Hong S; Kim JW; Yoon YS; Cho JY; Han HS; Jeong SH
APMIS; 2016 Mar; 124(3):208-15. PubMed ID: 26764243
[TBL] [Abstract][Full Text] [Related]
15. Liver Metastases of Neuroendocrine Tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas.
Jin M; Zhou X; Yearsley M; Frankel WL
Endocr Pathol; 2016 Sep; 27(3):253-8. PubMed ID: 27300354
[TBL] [Abstract][Full Text] [Related]
16. Glutamine Synthetase Immunoreactivity in Peritumoral Hyperplasia in Liver:  Case Report of a Metastatic Paraganglioma With Focal Nodular Hyperplasia-Like Changes and Review of an Additional 54 Liver Masses.
Bryant BH; Zenali MJ; Swanson PE; Upton MP; Yeh MM; Cuevas C; Park JO; Westerhoff M
Am J Clin Pathol; 2016 Aug; 146(2):254-61. PubMed ID: 27247379
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
18. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.
Kaseb AO; Hassan M; Lacin S; Abdel-Wahab R; Amin HM; Shalaby A; Wolff RA; Yao J; Rashid A; Vennapusa B; Feng J; Ohtomo T
Oncotarget; 2016 Oct; 7(43):69916-69926. PubMed ID: 27655712
[TBL] [Abstract][Full Text] [Related]
19. Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular Carcinoma.
Cao W; Sharma M; Imam R; Yu J
Am J Clin Pathol; 2019 Oct; 152(5):647-655. PubMed ID: 31305883
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Tumor Tissue Biopsy for Predicting the Biological Behavior of Hepatocellular Carcinoma.
Shioga T; Kondo R; Ogasawara S; Akiba J; Mizuochi S; Kusano H; Mihara Y; Tanigawa M; Kinjyo Y; Naito Y; Kuromatsu R; Nakashima O; Yano H
Anticancer Res; 2020 Jul; 40(7):4105-4113. PubMed ID: 32620659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
